GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) insider Frank Jimenez purchased 1,750 shares of the company's stock in a transaction dated Thursday, April 30th. The stock was bought at an average cost of $60.45 per share, for a total transaction of $105,787.50. Following the completion of the transaction, the insider owned 93,932 shares in the company, valued at approximately $5,678,189.40. This represents a 1.90% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
GE HealthCare Technologies Stock Performance
Shares of GEHC opened at $60.84 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The business's 50 day moving average price is $73.28 and its 200-day moving average price is $77.52. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The stock has a market cap of $27.76 billion, a P/E ratio of 14.56, a P/E/G ratio of 1.34 and a beta of 1.17.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts' consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same period in the prior year, the firm earned $1.01 earnings per share. The business's revenue for the quarter was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.9 earnings per share for the current fiscal year.
GE HealthCare Technologies Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies's payout ratio is currently 3.35%.
Key GE HealthCare Technologies News
Here are the key news stories impacting GE HealthCare Technologies this week:
- Positive Sentiment: Insiders bought shares — CEO Peter Arduini purchased 4,169 shares (~$59.92 avg) and director Frank R. Jimenez bought 1,750 shares; insider buys are often read as management confidence and can support the stock. SEC Form 4: Arduini
- Neutral Sentiment: Operational restructure — GEHC is combining Imaging and Advanced Visualization into a new Advanced Imaging Solutions unit and announced executive changes to improve execution; strategic but benefits may be multi‑quarter. BusinessWire: Operational Updates
- Neutral Sentiment: Wells Fargo set a new $75 price target (down from $97) but kept an overweight rating — implies upside vs. current levels but signals tempered near‑term expectations. AmericanBankingNews: Wells Fargo PT
- Negative Sentiment: Guidance cut and margin pressure — management trimmed FY26 EPS to $4.80–5.00, citing inflation, higher chip/oil/freight costs and supply‑chain pressures; this is the primary driver of the recent sell‑off. Reuters: Guidance Cut
- Negative Sentiment: Q1 was mixed but weak on profits — revenue beat (~$5.13B) but EPS missed ($0.99 vs $1.07 est.) and margins compressed, reinforcing short‑term downside risk. Zacks: Q1 Results
- Negative Sentiment: Analyst downgrades/price‑target cuts — Citigroup and JPMorgan trimmed targets to $65 (neutral), and other firms adjusted targets/ratings, signaling reduced near‑term expectations from sell‑side desks. AmericanBankingNews: Citigroup PT Cut
- Negative Sentiment: Investor litigation inquiry — Johnson Fistel is investigating potential claims relating to executives, adding legal/regulatory risk and headline volatility. GlobeNewswire: Litigation Notice
Analyst Ratings Changes
Several equities analysts recently issued reports on the company. Piper Sandler lowered their price objective on GE HealthCare Technologies from $96.00 to $88.00 and set an "overweight" rating on the stock in a research report on Friday, April 17th. Bank of America upped their price objective on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a "neutral" rating in a research report on Monday, January 5th. Evercore set a $80.00 price objective on GE HealthCare Technologies in a research report on Thursday. Wall Street Zen cut GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research report on Saturday, March 21st. Finally, Oppenheimer reaffirmed an "outperform" rating and issued a $85.00 price objective on shares of GE HealthCare Technologies in a research report on Thursday. Eight investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $80.67.
View Our Latest Stock Analysis on GE HealthCare Technologies
Institutional Investors Weigh In On GE HealthCare Technologies
A number of hedge funds have recently added to or reduced their stakes in GEHC. Auto Owners Insurance Co raised its stake in GE HealthCare Technologies by 9,525.4% during the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company's stock valued at $278,725,000 after buying an additional 33,629,559 shares during the last quarter. Norges Bank purchased a new stake in shares of GE HealthCare Technologies in the 4th quarter worth $596,024,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in shares of GE HealthCare Technologies in the 4th quarter worth $533,655,000. Capital Research Global Investors increased its stake in shares of GE HealthCare Technologies by 25.0% in the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company's stock worth $1,875,400,000 after purchasing an additional 4,998,154 shares in the last quarter. Finally, Cynosure Group LLC increased its stake in shares of GE HealthCare Technologies by 21,045.4% in the 4th quarter. Cynosure Group LLC now owns 4,365,462 shares of the company's stock worth $358,055,000 after purchasing an additional 4,344,817 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.
GE HealthCare Technologies Company Profile
(
Get Free Report)
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
